Sayankina et al. on Defining the Intension and Extension of Nations’ Sovereignty in the Age of Generative AI

Sofiya Sayankina (Hankuk U Foreign Studies) et al. have posted “Defining the Intension and Extension of Nations’ Sovereignty in the Age of Generative AI” on SSRN. Here is the abstract:

Generative Artificial Intelligence (GAI)’s wide-ranging potential for generation, communication and dissemination of information marks an unprecedented level of transformation by challenging states with varying approaches to state sovereignty. These implications underscore the necessity of examining how states maintain control over digital territories that are being reshaped by the increasing influence of GAI. In particular, we explore how economic, political and social circumstances will shape government regulations on AI. This research highlights the importance of debate concerning how the notion of sovereignty itself may be shaped amidst the proliferation of GAI.

Pradhan on Intellectual Property Strategies for AI-Enabled Drug Development

Nikhil Pradhan (Independent) has posted “Intellectual Property Strategies for AI-Enabled Drug Development” (Bringing Medicines to Life: How Intellectual Property Enables Innovation in the Life Sciences (eds. Jonathan M. Barnett and Bowman Heiden, Cambridge University Press, forthcoming 2026)) on SSRN. Here is the abstract:

Conventional biopharma IP strategy, focused on tangible drug assets, faces disruption on several fronts. AI-driven drug discovery technologies continue to improve and bring candidates into trials, if not yet to full FDA approval. Greater awareness of the high cost and failure rate of traditionally developed drugs is also highlighting the potential of AI technologies to bring drugs to market faster and with lower cost. The impending patent cliff for several blockbuster drugs will also lead firms to reevaluate efforts allocated to asset-focused patent protection. In addition, more stringent disclosure requirements for AI technologies used in drug development may shift the line on the tradeoff between patent and trade secret protection.

This chapter will outline these disruptions as well as the current AI drug development landscape, including identifying trends on how AI-focused firms are currently allocating resources to assets, specific targets or modalities, and/or underlying AI technologies. In view of this landscape and other disruptions in the biopharma market, the chapter will outline actionable IP strategies for players across the landscape including academic institutions, early-stage companies, and large pharmaceutical enterprises. Specific considerations for executing on IP strategies and other approaches for establishing exclusivity around new technologies and business models will be evaluated, including guidance on the patent vs. trade secret decision and tactics to strengthen patent applications for examination and litigation success, enabling stakeholders to adapt and thrive in this evolving landscape.

Torrance et al. on Governance of the A.I., by the A.I., and for the A.I.

Andrew W. Torrance (U Kansas Law) and Bill Tomlinson (U California) have posted “Governance of the A.I., by the A.I., and for the A.I.” (93 Miss. L. J. 107) on SSRN. Here is the abstract:

Over the past half century, there have been several false dawns during which the “arrival” of world-changing artificial intelligence (AI) has been heralded. Tempting fate, the authors believe the age of AI has, indeed, finally arrived. Powerful image generators, such as DALL-E2 and Midjourney have suddenly allowed anyone with access the ability easily to create rich and complex art. In a similar vein, text generators, such as GPT3.5 (including ChatGPT) and BLOOM, allow users to compose detailed written descriptions of many topics of interest. And, it is even possible now for a person without extensive expertise in writing software to use AI to generate code capable of myriad applications. While AI will continue to evolve and improve, probably at a rapid rate, the current state of AI is already ushering in profound changes to many different sectors of society. Every new technology challenges the ability of humanity to govern it wisely. However, governance is usually viewed as both possible and necessary due to the disruption new technology often poses to social structures, industries, the environment, and other important human concerns. In this article, we offer an analysis of a range of interactions between AI and governance, with the hope that wise decisions may be made that maximize benefits and minimize costs. The article addresses two main aspects of this relationship: the governance of AI by humanity, and the governance of humanity by AI. The approach we have taken is itself informed by AI, as this article was written collaboratively by the authors and ChatGPT.

Kannegieter on Nondeterministic Torts: A Mechanistic Approach to Large Language Model Tort Liability

Trent Kannegieter (Yale U Law) has posted “Nondeterministic Torts: A Mechanistic Approach to Large Language Model Tort Liability” on SSRN. Here is the abstract:

Our laws were built for deterministic machines. When given the same inputs, we expect a system to consistently produce the same outputs. But modern artificial intelligence (AI) systems, specifically large language models (LLMs) and other types of “generative AI” (GenAI), challenge this assumption. These systems are nondeterministic, meaning that they produce varied outputs even when given identical inputs. By their nature, nondeterministic LLM-based predictions carry an arbitrary randomness that is an inherent feature, not a bug, of the product.

Even as AI applications spread rapidly, liability for AI systems going wrong remains an open question. But despite the rise of attention and scholarship around artificial intelligence since the “GenAI explosion” sparked by ChatGPT’s release in fall 2022, researchers have so far overlooked nondeterminism’s profound consequences for the law of AI.

This article argues that nondeterminism is the key link to successfully arguing a host of tort claims against the creators and deployers of AI products when these products cause injury. The inherent dangers of deploying a nondeterministic, LLM-based system give rise to multiple potential tort claims, especially when AI systems are deployed in contexts that aresafety-critical (where the cost of individual errors is comparatively high) oragentic (when AI agents have comparatively few checks from humans or deterministic software). Even if the average legal reader isn’t aware of nondeterminism, the average AI engineer is. By deploying a system that is known to be nondeterministic and unpredictable, developers might be accepting responsibility for the harms that emerge from a model’s behavior.

Nondeterminism is the critical hook into multiple popular tort doctrines, especially negligence and product liability (design defect) claims. In claims of negligence, developer knowledge of nondeterminism helps establish a duty and makes even nominally unexpected harms foreseeable, as they are downstream from an unpredictable, nondeterministic system. In product liability, nondeterministic systems deployed in safety-critical or agentic contexts might be a defective design for their use case. Quality assurance (QA) procedures, critical to ensuring the safety of mission-critical systems, are inherently incomplete for nondeterministic systems. Nondeterminism might even make deploying an LLM-based system in such contexts an abnormally dangerous activity, further strengthening the case for a strict liability regime.

This piece arrives at a critical moment in the development of common law around AI. AI might be eating the world, but regulation has not kept pace. Little federal legislative movement is expected, leaving soft law (industry self-regulation) as a stopgap. But the rewards for AI companies deploying quickly in an era of skyrocketing valuations will likely prove too large to ignore. Without a clear liability regime, firms see little costs to counter the lucrative benefits of capturing the AI market. Absent additional regulation, the common law as it stands today is the best tool in today’s toolkit to guard against AI harms.

The article offers a novel, mechanistic approach to assessing AI liability in high-stakes domains: beginning with technical and use case specificity. By looking at the technical features of products on the market today, we can discover ways to use existing doctrine to regulate new technologies. Inquiries into the law of AI must begin with how AI systems work. This framework could drive meaningful reforms, helping strengthen the effort of using tort law to guard against AI harms without having to rely on speculative future harms. If utilized, the arguments within this piece might incentivize AI product developers—the least cost avoiders—to only deploy agentic GenAI systems when the benefits exceed the costs.

Baste et al. on Open Justice Data in Europe: A Patchwork

Øystein Baste (U Oslo) et al. have posted “Open Justice Data in Europe: A Patchwork” on SSRN. Here is the abstract:

The publication of court judgments is essential to upholding rule of law and democratic norms as well as facilitating legal research, and new legal technologies. However, many European states struggled to transition to online publication at scale. In this article we address three questions: what are the obligations of states to publish judgments; which states are making progress; and what are the challenges and solutions in ensuring greater publicity? We examine the overarching duties in the ECHR and EU law and the relevant legal requirements and practice in 12 national jurisdictions and two regional courts. Our findings show tremendous variation in duties and practice, and identify barriers to progress (legal, organisational, and budgetary) but also promising innovative solutions in certain jurisdictions. Ultimately, while this publication diversity provides a form of experimental governance, it would be timely to move towards common standards and approaches.

Arcila on AI Liability Along the Value Chain

Beatriz Botero Arcila (Institut d’Etudes Politiques Paris (Sciences Po) Sciences Po Law Ecole Droit Sciences Po) has posted “AI Liability Along the Value Chain” (Published by Mozilla Foundation) on SSRN. Here is the abstract:

Policymakers around the world are increasingly preoccupied with identifying mechanisms to better assign accountability and liability throughout the AI value chain. Particularly in the EU, discussions around civil liability and AI received significant attention after the proposal of an AI Liability Directive (AILD) in 2022. While this proposal was recently withdrawn by the European Commission, the challenges posed by AI for civil liability and harmed individuals’ ability to seek redress remain more relevant than ever amid increasing adoption of AI across sectors. 

This report thus seeks to provide more conceptual clarity to these challenges and provide recommendations on what an effective AI liability framework could look like. Though it is common to think of AI systems as a singular tool, AI systems are often developed and deployed in a value chain that involves numerous actors that participate throughout the stages of creation, fine-tuning, and implementation of these technologies, or that sell and supply key components such as pre-labeled data. 

When designing a liability system for this type of multi-party scenario, there are many questions to consider: should all parties in the value chain be held equally liable when harm occurs? Or should each actor only be held liable for the extent to which they are responsible? How easy is it to establish the contribution of each party? (Spoiler alert, it may be very hard.) Another question lawyers will be familiar with is what is the right standard — should AI actors be held liable only when they fail to take the right safety measures? Or should they be held liable regardless of whether they took safety measures, simply because by developing or deploying an AI system or model they created a risk? 

This Report discusses these questions and the complexities of assigning liability along the AI value chain, given the involvement of multiple actors in the design, development, and deployment of AI systems. The Report explores various configurations of AI value chains, the roles of different actors, and how companies allocate liability amongst them via contracts and terms. It then examines different policy choices for designing liability regimes.

Yildirim on On Artificial Intelligence and Network Effects

Pinar Yildirim (U Pennsylvania The Wharton) has posted “On Artificial Intelligence and Network Effects” on SSRN. Here is the abstract:

Network effects have long been identified as a significant driver of growth for digital platforms. Emergence of artificial intelligence (AI) technologies stands to interact with network effects in significant ways. While several scholars argued that network effects can accelerate the success of AI, it remains less clear how AI-enabled tools themselves might reshape the competitive advantage digital platforms gain from network effects. In this article, I examine the implications of AI tools for network effects. I argue that while some use cases of AI can amplify network effects, others may weaken them. In particular, when the AI tools reduce search and production costs and reduces shared experiences among consumers, AI may reduce the importance of network effects to a digital platform. The paper concludes with the note that new technologies such as AI can have important implications for competition policy and antitrust enforcement.

Trout on When Does Regulation by Insurance Work? The Case of Frontier AI

Cristian Trout (Artificial Intelligence Underwriting Company) has posted “When Does Regulation by Insurance Work? The Case of Frontier AI” on SSRN. Here is the abstract:

No one doubts the utility of insurance for its ability to spread risk or streamline claims management; much debated is when and how insurance uptake can improve welfare byreducing harm, despite moral hazard. Proponents and dissenters of “regulation by insurance” have now documented a number of cases of insurers succeeding or failing to have such anet regulatory effect (in contrast with a net hazard effect). Collecting these examples together and drawing on an extensive economics literature, this Article develops a principled framework for evaluating insurance uptake’s effect in a given context. The presence of certain distortions – including judgment-proofness, competitive dynamics, and behavioral biases – createspotential for a net regulatory effect. How much of that potential gets realized then depends on the type of policyholder, type of risk, type of insurer, and the structure of the insurance market. The analysis suggests regulation by insurance can be particularly effective for catastrophic non-product accidents where market mechanisms provide insufficient discipline and psychological biases are strongest. As a demonstration, the framework is applied to the frontier AI industry, revealing significant potential for a net regulatory effect but also the need for policy intervention to realize that potential. One option is a carefully designed mandate that encourages forming a specialized insurer or mutual, focuses on catastrophic rather than routine risks, and bars pure captives.

Thudumu on How to Measure ROI for AI

Srikanth Thudumu (Institute Applied Artificial Intelligence and Robotics (IAAIR)) has posted “How to Measure ROI for AI” on SSRN. Here is the abstract:

Return on Investment (ROI) is often used as the primary metric for evaluating Artificial Intelligence (AI) projects. However, conventional ROI calculations tend to focus narrowly on short-term, directly attributable savings while overlooking enabling capabilities, strategic options, and risk reduction. Historical technology shifts such as the automobile, electrification, and the internet reveal that value typically emerges after complementary investments and operational redesign. This working paper explains why conventional ROI lenses can be misleading, distills lessons from past transformations, and proposes a simple “Smart ROI” framework with a practical measurement playbook for organizations.

Smith et al. on Regulating Robotaxis

Bryant Walker Smith (U South Carolina Joseph F. Rice Law) and Matthew Wansley (Yeshiva U Benjamin N. Cardozo Law) have posted “Regulating Robotaxis” (99 Southern California Law Review 603 (2026)) on SSRN. Here is the abstract:

In several sunbelt cities, commercial robotaxi service has arrived. The leading robotaxi company is providing over 400,000 trips per week. The industry claims that robotaxis will save lives and provide convenient and affordable mobility. Critics counter that they will increase congestion, undermine transit, and subject the public to ubiquitous surveillance. We argue that the social impact of robotaxis depends on how they are regulated. We emphasize two points missing from the debate. First, some of the benefits of robotaxis may be political rather than technological—some longstanding public policy goals may become viable in a robotaxi world. Second, letting one private company dominate the transportation system risks monopoly abuse—and regulators can act now to prevent it.

In this Article, we offer a plan to regulate robotaxis. Carefully crafted externality regulation can address pollution, congestion, wear-and-tear on infrastructure, and privacy risks while minimizing distortions in choices between travel modes. Regulators can promote competition by permitting open entry, banning lock-in contracts, and enabling one-stop access to competing networks. And they can protect riders even if competition fails by mandating that fares be transparent and rider-neutral and requiring that robotaxi companies maintain a fleet sufficient for emergencies. Policymakers should take advantage of robotaxi deployment to reimagine the transportation system—liberate land from the tyranny of parking, refocus mass transit investments on high-throughput routes, and expand mobility for people with low incomes and people with disabilities.